Financial toxicity describes the financial burden and distress that can arise for patients, and
their family members, as a result of cancer treatment. It includes direct out-of-pocket costs for …

Background Financial toxicity has traditionally been attributed to the rising costs of cancer
care. As ability to work impacts one's financial situation, limited employment and reduced …

Context No information is available on oncology patients' level of stress and symptom
burden during the coronavirus disease 2019 (COVID-19) pandemic. Objectives To evaluate …

Background: With rising costs of cancer care, this study aims to estimate the prevalence of,
and factors associated with, medical financial hardship intensity and financial sacrifices due …

Background This work aims to evaluate the role of digital health in supporting the mental
and psychological well-being of patients with cancer and identify the associated challenges …

Introduction The costs associated with cancer diagnosis, treatment and care present
enormous financial toxicity. However, evidence of financial toxicity associated with cancer in …

Background Symptom networks can provide empirical evidence for the development of
personalized and precise symptom management strategies. However, few studies have …

Objectives Financial toxicity is recognized as an important adverse effect of cancer treatment
that may decrease patients' health-related quality of life (HRQOL). We aim to perform a …

It is widely acknowledged that cancer affects not only patients but also their friends and
family members who provide informal, and typically unpaid, care. Given the dual impact that …

Context Financial toxicity (FT) refers to the detrimental effects of financial strain caused by a
cancer diagnosis on the well-being of patients and their families. It is highly prevalent among …